Developer of novel therapeutics intended to treat cancer. The company looks at the genomic mutations in the context of the patient's specific case to select and sequence treatments, including immunotherapies, enabling them to identify their genomic sequence, execute a precision treatment plan as well as monitor and coordinate their care.